NCT06587100View on ClinicalTrials.gov

Wearable Activity Tracking to Curb Hospitalizations

RecruitingOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

April 7, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Hematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm
Interventions
DEVICE

Fitbit

Participants will wear Fitbit device

DEVICE

Apple HealthKit-based devices

Participants will wear personal device and share data with study team.

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER